Global biotechnology leapfrogging during the COVID-19 pandemic: a trend to stay?

IF 14.3 1区工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Trends in biotechnology Pub Date : 2024-11-01 Epub Date: 2024-06-15 DOI:10.1016/j.tibtech.2024.05.007

Elena Borzova

引用次数: 0

Abstract

The coronavirus disease 2019 (COVID-19) pandemic created the demand and the permissive conditions for innovative solutions, superior business models, digital technologies, funding, and licensing in biotechnology, fostering a phenomenon that might be called 'leapfrogging.' Despite a postpandemic macroeconomic downturn, a focus on radical innovation remained with crucial ramifications for biomedical challenges beyond COVID-19.

查看原文本刊更多论文

COVID-19 大流行期间全球生物技术的飞跃发展：趋势是否会持续？

2019 年冠状病毒病（COVID-19）大流行为生物技术领域的创新解决方案、卓越的商业模式、数字技术、资金和许可创造了需求和有利条件，促成了一种可称为 "跨越式发展 "的现象。尽管疫情过后宏观经济下滑，但对激进创新的关注依然存在，这对 COVID-19 之后的生物医学挑战产生了至关重要的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Trends in biotechnology 工程技术-生物工程与应用微生物

CiteScore

28.60

自引率

1.20%

发文量

198

审稿时长

1 months

期刊介绍： Trends in Biotechnology publishes reviews and perspectives on the applied biological sciences, focusing on useful science applied to, derived from, or inspired by living systems. The major themes that TIBTECH is interested in include: Bioprocessing (biochemical engineering, applied enzymology, industrial biotechnology, biofuels, metabolic engineering) Omics (genome editing, single-cell technologies, bioinformatics, synthetic biology) Materials and devices (bionanotechnology, biomaterials, diagnostics/imaging/detection, soft robotics, biosensors/bioelectronics) Therapeutics (biofabrication, stem cells, tissue engineering and regenerative medicine, antibodies and other protein drugs, drug delivery) Agroenvironment (environmental engineering, bioremediation, genetically modified crops, sustainable development).